Clinical Trial Update: Telmisartan Pilot Study on Treatment Resistant Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 pilot study on telmisartan for treatment-resistant schizophrenia was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Treatment-resistant Schizophrenia

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Xiaoduo Fan | Conditions: Schizophrenia, Schizo Affective Disorder | Phase 2 | Status: TERMINATED | Results posted: 2022-03-02